Skip to main content
. Author manuscript; available in PMC: 2024 Jun 26.
Published in final edited form as: Lancet Oncol. 2022 Dec 6;24(1):77–90. doi: 10.1016/S1470-2045(22)00694-5

Figure 2: Kaplan-Meier survival curves.

Figure 2:

Invasive disease-free survival in the ITT population at the second overall survival interim analysis. (B) Distant relapse-free survival in the ITT population at the second overall survival interim analysis. (C) Overall survival in the ITT population at the second overall survival interim analysis. Vertical dashes denote censored patients. HR=hazard ratio. ITT=intention to treat.

HHS Vulnerability Disclosure